Chronic Hand Eczema Clinical Trial
Official title:
Chronic Hand Eczema - Self-management and Prognosis
Hand eczema is a common disease which often gives a chronic course thus affecting many functions in daily life. The body of evidence related to self-management of chronic hand eczema is poor. Better methods to support self-management of patients with chronic hand eczema may potentially improve the prognosis of a disease which is both a tremendous burden to the individual and to the society. The purpose of this trial is to evaluate the effect of a newly designed guidance programme offering individual counselling compared to conventional information with written information sheets.
Detailed description of the trial and the intervention can be found in the publication:
Mollerup A, Veien NK, Johansen JD. Chronic hand eczema--self-management and prognosis: a
study protocol for a randomised clinical trial'. BMC Dermatol. 2012 Jun 12;12:6. doi:
10.1186/1471-5945-12-6.
PMID: 22691871 [PubMed - indexed for MEDLINE] Free PMC Article
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05545215 -
Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema
|
||
| Completed |
NCT05486117 -
Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema
|
Phase 1 | |
| Recruiting |
NCT06004050 -
A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema
|
Phase 3 | |
| Recruiting |
NCT05682859 -
Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)
|
Phase 4 | |
| Recruiting |
NCT05994976 -
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
|
||
| Completed |
NCT03683719 -
Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema
|
Phase 2 | |
| Completed |
NCT04872101 -
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)
|
Phase 3 | |
| Completed |
NCT04871711 -
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
|
Phase 3 | |
| Recruiting |
NCT05026554 -
Characterization of Chronic Hand Eczema
|
||
| Completed |
NCT05259722 -
A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
|
Phase 3 | |
| Recruiting |
NCT03861455 -
Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids
|
Phase 2 | |
| Recruiting |
NCT05355818 -
Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema
|
Phase 3 | |
| Completed |
NCT04949841 -
Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials
|
Phase 3 | |
| Completed |
NCT03246776 -
Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan
|
Phase 4 | |
| Not yet recruiting |
NCT06283550 -
Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
|
Phase 2 | |
| Completed |
NCT04378569 -
Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema
|
Phase 1/Phase 2 |